ONYX PHARMACEUTICALS INC Increase (Decrease) in Restricted Cash
ONYX PHARMACEUTICALS INC reported Increase (Decrease) in Restricted Cash of -$31.91 million for the 12-month period ending 2011-12-31, per its 10-K filed 2013-02-28.
Discontinued › Notes
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2013-02-28
- ONYX PHARMACEUTICALS INC increase (decrease) in restricted cash for the quarter ending 2011-12-31 was $0.00.
- ONYX PHARMACEUTICALS INC increase (decrease) in restricted cash for the quarter ending 2011-09-30 was $0.00.
- ONYX PHARMACEUTICALS INC increase (decrease) in restricted cash for the quarter ending 2011-06-30 was $0.00, a 100.00% decline year-over-year.
- ONYX PHARMACEUTICALS INC increase (decrease) in restricted cash for the quarter ending 2011-03-31 was -$31.91M.
- ONYX PHARMACEUTICALS INC increase (decrease) in restricted cash for fiscal 2011 was -$31.91M, a 897.75% decline from fiscal 2010.
- ONYX PHARMACEUTICALS INC increase (decrease) in restricted cash for fiscal 2010 was $4.00M.
- ONYX PHARMACEUTICALS INC increase (decrease) in restricted cash for fiscal 2009 was $0.00.
- ONYX PHARMACEUTICALS INC increase (decrease) in restricted cash for fiscal 2008 was $0.00.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month |
|---|---|---|---|---|
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $0.00 derived: sum of 2 quarters · filed 2013-02-28 | $0.00 derived: sum of 3 quarters · filed 2013-02-28 | -$31.91M 10-K · filed 2013-02-28 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $0.00 derived: sum of 2 quarters · filed 2012-11-02 | -$31.91M 10-Q · filed 2012-11-02 | -$31.91M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | -$31.91M 10-Q · filed 2012-08-06 | -$31.91M derived: sum of 3 quarters · filed 2013-02-28 | -$31.91M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-03-31 | -$31.91M 10-Q · filed 2012-05-04 | -$31.91M derived: sum of 2 quarters · filed 2013-02-28 | -$31.91M derived: sum of 3 quarters · filed 2013-02-28 | -$27.91M derived: sum of 4 quarters · filed 2013-02-28 |
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $0.00 derived: sum of 2 quarters · filed 2013-02-28 | $4.00M derived: sum of 3 quarters · filed 2013-02-28 | $4.00M 10-K · filed 2013-02-28 |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $4.00M derived: sum of 2 quarters · filed 2011-11-03 | $4.00M 10-Q · filed 2011-11-03 | $4.00M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-06-30 | $4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-09 | $4.00M 10-Q · filed 2011-08-09 | $4.00M derived: sum of 3 quarters · filed 2012-02-27 | |
| 2010-03-31 | $0.00 10-Q · filed 2011-05-10 | $0.00 derived: sum of 2 quarters · filed 2012-02-27 | ||
| 2009-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $0.00 10-K · filed 2012-02-27 | ||
| 2009-09-30 | $0.00 10-Q · filed 2010-11-03 | |||
| 2008-12-31 | $0.00 10-K · filed 2011-02-23 |